미국 - 영어 - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 0.5 mg - benztropine mesylate tablets, usp are indicated for use as an adjunct in the therapy of all forms of parkinsonism. useful also in the control of extrapyramidal disorders (except tardive dyskinesia - see precautions ) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to benztropine mesylate tablets or to any component of the tablets. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients. because of the atropine-like side effects, benztropine mesylate should be used with caution in pediatric patients over three years of age (see contraindications ).

미국 - 영어 - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 1 mg in 1 ml - for use as an adjunct in the therapy of all forms of parkinsonism (see dosage and administration ). useful also in the control of extrapyramidal disorders (except tardive dyskinesia — see precautions ) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to any component of benztropine mesylate. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.

미국 - 영어 - NLM (National Library of Medicine)

oceanside pharmaceuticals - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate 4 mg in 1 ml - dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches with or without aura. dihydroergotamine mesylate nasal spray is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp 3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore contraindicated (see warnings, cyp 3a4 inhibitors ). dihydroergotamine mesylate nasal spray should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have clinical symptoms

미국 - 영어 - NLM (National Library of Medicine)

fresenius kabi usa, llc - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 1 mg in 1 ml - for use as an adjunct in the therapy of all forms of parkinsonism (see dosage and administration ). useful also in the control of extrapyramidal disorders (except tardive dyskinesia — see precautions ) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to any component of benztropine mesylate injection. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.

미국 - 영어 - NLM (National Library of Medicine)

akorn - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 1 mg in 1 ml - for use as an adjunct in the therapy of all forms of parkinsonism (see dosage and administration). useful also in the control of extrapyramidal disorders (except tardive dyskinesia – see precautions) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to any component of benztropine mesylate injection, usp. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.

미국 - 영어 - NLM (National Library of Medicine)

american regent, inc. - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 1 mg in 1 ml - for use as an adjunct in the therapy of all forms of parkinsonism. useful also in the control of extrapyramidal disorders (except tardive dyskinesia — see precautions) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to any component of benztropine mesylate injection. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.

미국 - 영어 - NLM (National Library of Medicine)

nexus pharmaceuticals inc - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 1 mg in 1 ml - for use as an adjunct in the therapy of all forms of parkinsonism. useful also in the control of extrapyramidal disorders (except tardive dyskinesia --- see precautions) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to any component of benztropine mesylate injection. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients. because of the atropine-like side effects, benztropine mesylate should be used with caution in pediatric patients over three years of age (see contraindications).

미국 - 영어 - NLM (National Library of Medicine)

par pharmaceutical, inc. - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 0.5 mg - benztropine mesylate tablets usp are indicated for use as an adjunct in the therapy of all forms of parkinsonism. useful also in the control of extrapyramidal disorders (except tardive dyskinesia – see precautions) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to benztropine mesylate tablets or to any component of the tablets. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.

미국 - 영어 - NLM (National Library of Medicine)

state of florida doh central pharmacy - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 0.5 mg - for use as an adjunct in the therapy of all forms of parkinsonism. useful also in the control of extrapyramidal disorders (except tardive dyskinesia - see precautions) due to neuroleptic drugs (e.g., phenothiazines). hypersensitivity to benztropine mesylate tablets or to any component of the tablets. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age, and should be used with caution in older pediatric patients.

미국 - 영어 - NLM (National Library of Medicine)

rebel distributors corp - benztropine mesylate (unii: wmj8tl7510) (benztropine - unii:1nhl2j4x8k) - benztropine mesylate 2 mg - indications and usage: for use as an adjunct in the therapy of all forms of parkinsonism. useful also in the control of extrapyramidal disorders (except tardive dyskinesia - see precautions ) due to neuroleptic drugs (e.g., phenothiazines). contraindications: hypersensitivity to benztropine mesylate tablets. because of its atropine-like side effects, this drug is contraindicated in pediatric patients under three years of age and should be used with caution in older pediatric patients. pediatric use: because of the atropine-like side effects, benztropine mesylate should be used with caution in pediatric patients over three years of age (see contradictions ).